A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening program.

ABSTRACT:

Purpose

To validate the potential application of THEIA™ as clinical decision making assistant in a national screening program.

Methods

A total of 900 patients were recruited from either an urban large eye hospital, or a semi-rural optometrist led screening provider, as they were attending their appointment as part of New Zealand Diabetic Eye Screening Programme. The de-identified images were independently graded by three senior specialists, and final results were aggregated using New Zealand grading scheme, which was then converted to referable/non-referable and Healthy/mild/more than mild/sight threatening categories.

Results

THEIA™ managed to grade all images obtained during the study. Comparing the adjudicated images from the specialist grading team, "ground truth"

SUBMITTER: Vaghefi E 

PROVIDER: S-EPMC10219993 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature